Literature DB >> 6699335

Lean body mass is a predictor of the daily requirement for thyroid hormone in older men and women.

J J Cunningham, U S Barzel.   

Abstract

Levothyroxine (T4) replacement need in adults with primary hypothyroidism has recently been reported to fall with age. Previous studies have demonstrated that the resting metabolic rate falls with age in euthyroid adults and that this fall is proportional to a reduction in lean body mass (LBM). Since LBM is correlated also with 24-hour energy expenditure, this study examined the possibility that LBM might be an accurate predictor of T4 requirement. Seventy-five hypothyroid adults receiving full replacement therapy, ranging in age from 24 to 88 years, were studied retrospectively. Lean body mass was found to be a better predictor of T4 requirement than age or weight for the entire group as well as for subgroups of men and women 51 years old and older. The age-related reduction in LBM may be responsible for the reported decrease in the rate of fractional thyroxine degradation with age.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699335     DOI: 10.1111/j.1532-5415.1984.tb02003.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  18 in total

1.  Levothyroxine replacement doses are affected by gender and weight, but not age.

Authors:  Madhuri Devdhar; Rebecca Drooger; Marieta Pehlivanova; Gurdeep Singh; Jacqueline Jonklaas
Journal:  Thyroid       Date:  2011-07-13       Impact factor: 6.568

2.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

3.  Age and the thyrotropin response to hypothyroxinemia.

Authors:  Rebecca Over; Sonia Mannan; Hala Nsouli-Maktabi; Kenneth D Burman; Jacqueline Jonklaas
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

Review 4.  Optimal differentiated thyroid cancer management in the elderly.

Authors:  Donald S A McLeod; Kelly Carruthers; Dev A S Kevat
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

5.  Aging and the thyroid.

Authors:  K A Woeber
Journal:  West J Med       Date:  1985-11

6.  Thyroid disease in the elderly--missed diagnosis or overdiagnosis?

Authors:  M J Rosenthal; C J Sanchez
Journal:  West J Med       Date:  1985-11

Review 7.  Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment.

Authors:  Peter Laurberg; Stig Andersen; Inge Bülow Pedersen; Allan Carlé
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 8.  Hormone replacement after thyroid and parathyroid surgery.

Authors:  Andreas Schäffler
Journal:  Dtsch Arztebl Int       Date:  2010-11-26       Impact factor: 5.594

9.  Stable Isotope Pharmacokinetic Studies Provide Insight into Effects of Age, Sex, and Weight on Levothyroxine Metabolism.

Authors:  Islam R Younis; Mariam A Ahmed; Kenneth D Burman; Offie P Soldin; Jacqueline Jonklaas
Journal:  Thyroid       Date:  2018-01-02       Impact factor: 6.568

10.  Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.

Authors:  Ana B Santoro; Daniela D Vargens; Mateus de Camargo Barros Filho; Daniel A Bulzico; Luiz Paulo Kowalski; Ricardo M R Meirelles; Daniela P Paula; Ronaldo R S Neves; Cencita N Pessoa; Claudio J Struchine; Guilherme Suarez-Kurtz
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.